Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
10/2007
10/10/2007CN100341870C Glycosidase inhibitors and preparation thereof
10/10/2007CN100341853C Taxane with alkyl subtituted lateral chain and medicinal composition containing said compound
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279498 Substituted aryl amides as IP antagonists
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279488 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions
10/09/2007US7279481 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone; therapy of depression or anxiety
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007CA1341557C Novel triazole and imidazole compounds
10/04/2007WO2007111323A1 Ureide derivative and use thereof for medical purposes
10/04/2007WO2007111212A1 Triazolone derivative
10/04/2007WO2007111176A1 Organic electroluminescence element material and organic electroluminescence element using such material
10/04/2007WO2007110667A1 Piperidines and related compounds for the treatment of dementia
10/04/2007WO2007110418A2 Substituted 5-hetaryl-4-aminopyrimidines
10/04/2007WO2007110344A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007WO2007110337A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007WO2007072201A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/04/2007US20070232811 Sterically hindered pi-bridge nonlinear optical chromophores, processes including same, and devices therefrom
10/04/2007US20070232719 1,1-Disubstituted 2-vinylcyclopropanes; free radical polymerizable monomers; dental materials, in particular as dental adhesives, fixing cements or filling composites; low polymerization shrinkage, good mechanical properties
10/04/2007US20070232678 (4, 5, 6, 7-Tetrahydro-1-H-Indol-7-Yl) Acetic Acid Derivatives for Treatment of Alzheimer's Disease
10/04/2007US20070232663 Small molecule insulin mimetics absent quinones
10/04/2007US20070232662 Indol-2-One Derivatives for the Treatment of Central Nervous Disorders, Gastrointestinal Disorders and Cardiovascular Disorders
10/04/2007US20070232659 Novel Alkyl Substituted Piperidine Derivatives as Monoamine Neurotransmitter Re-Uptake Inhibitors
10/04/2007US20070232655 2-Pyridinylcycloalkylcarboxamide Derivatives Useful as Fungicides
10/04/2007US20070232648 Modulators of the glucocorticoid receptor and method
10/04/2007US20070232618 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
10/04/2007US20070232617 Indole-type derivatives as inhibitors of p38 kinase
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232602 Thiophene Derivatives, Their Manufacture and Use as Pharmaceutical Agents
10/04/2007US20070232600 Anti-migraine treatments
10/04/2007US20070232583 Central nervous system disorders; metabotropic glutamate receptors (mGluR); 2-(4-Pyridin-3-yl-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyrimidine
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007CA2647603A1 Ureide derivative and use thereof for medical purposes
10/04/2007CA2647423A1 Triazolone derivative
10/04/2007CA2647290A1 Piperidines and related compounds for the treatment of dementia
10/04/2007CA2646952A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007CA2646732A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
10/04/2007CA2645779A1 Substituted 5-hetaryl-4-aminopyrimidines
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1838701A1 N-substituted heterocyclic sulfonamides
10/03/2007EP1838690A2 Compounds with kv4 ion channel activity
10/03/2007EP1838304A2 Heterocyclic aspartyl protease inhibitors
10/03/2007EP1622874B1 3,4-dihydro-1h-quinolin-2-one derivatives as norepinephrine reuptake inhibitors
10/03/2007EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/03/2007EP1583756B1 Thiophene carboxamides as inhibitors of the enzyme ikk-2
10/03/2007EP1529044B1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/03/2007EP1519932B1 Bisarylsulfonamide compounds and their use in cancer therapy
10/03/2007EP1456180B1 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1173421B1 Indole derivatives as anti-inflammation agents
10/03/2007CN101048465A Polymeric luminescent material composition and polymeric light-emitting device
10/03/2007CN101048399A 4-hetero aryl methyl substituted phthalazinone derivatives
10/03/2007CN101048397A 6-(pyridinyl)-4-pyrimidone derivates as tau protein kinase 1 inhibitors
10/03/2007CN101048388A Quinazolinone derivatives and their use as B-Raf inhibitors
10/03/2007CN101048386A 嘧啶衍生物 Pyrimidine derivatives
10/03/2007CN101048383A 促性腺激素释放激素受体拮抗剂 Gonadotropin-releasing hormone receptor antagonist
10/03/2007CN101048374A Mercaptoamides as histone deacetylase inhibitors
10/03/2007CN100340556C Novel aryllimidazole derivatives, preparation and therapeutic used thereof
10/03/2007CN100340548C Novel arylheteroalkylamine derivatives
10/03/2007CN100340298C Near infrared fluorescent contrast agent and method for fluorescence imaging
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007US7276608 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders
10/02/2007US7276607 5-HT7 receptor antagonists
10/02/2007US7276606 Phenantridine analogues and uses thereof
10/02/2007US7276603 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer
10/02/2007US7276531 G-lactam derivatives as prostaglandin agonists
10/02/2007US7276524 Compounds as antumor agents or immunosuppressants
10/02/2007US7276522 dextrorotatory and levo-rotatory enantiomers; specific to alpha2B adrenergic receptors
10/02/2007US7276520 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
10/02/2007US7276518 For therapy of neuropathic or chronic pain
10/02/2007US7276516 P-indolyl-, indazolyl- and pyrrolopyridyl-sulfonylbenzamides, e.g., N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; modulators of the Cannabinoid-1 receptor, especially useful for treating obesity
10/02/2007CA2330756C Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation
10/02/2007CA2283242C Pesticidal 1-arylpyrazoles
10/02/2007CA2203417C Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis
10/02/2007CA2160912C 3-(het)arylcarboxylic acid derivatives, their preparation and intermediates for their preparation
09/2007
09/27/2007WO2007109334A2 Sip receptor modulating compounds and use thereof
09/27/2007WO2007107965A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
09/27/2007WO2007107539A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/27/2007WO2007107373A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
09/27/2007WO2007022241A3 Novel high affinity quinoline-based kinase ligands
09/27/2007US20070225349 Substituted 4-(Indazol-3-yl)phenols
09/27/2007US20070225335 Pyrazole Derivatives for Treating Condit Ions Mediated by Activation of the Adeno Sine A2B or A3 Receptor
09/27/2007US20070225329 Aryl aniline beta2 adrenergic receptor agonists
09/27/2007US20070225321 2,4-pyrimidinediamine compounds and their uses
09/27/2007US20070225319 Piperidinyl indole and tetrohydropyridinyl indole derivatives and methods of their use
09/27/2007US20070225308 2-Amino Quinazoline Derivative
09/27/2007US20070225296 Arylalkylamine Compound and Process for Preparing the Same
09/27/2007US20070225287 Substituted Arylpyrazines
09/27/2007CA2679980A1 S1p receptor modulating compounds and use thereof
09/27/2007CA2647024A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
09/27/2007CA2646585A1 Compounds which potentiate ampa receptor and uses thereof in medicine
09/27/2007CA2645867A1 Substituted gamma lactams as prostaglandin ep2 agonists
09/27/2007CA2645546A1 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases
09/27/2007CA2645426A1 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses
09/26/2007EP1837332A1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
09/26/2007EP1836203A2 Heteroaryl substituted quinolin-4-ylamine analogues
09/26/2007EP1836198A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments
09/26/2007EP1836197A1 Selective muscle relaxant and pharmaceutical compositions
09/26/2007EP1836196A1 Tricyclic delta-opioid modulators
1 ... 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 ... 523